Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125506431 | 12550643 | 1 | I | 20160704 | 20160712 | 20160712 | EXP | US-BAUSCH-BL-2016-016671 | BAUSCH AND LOMB | QAQISH I, SCHLAM I, CHAKKERA H, FONSECA R, ADAMSKI J. CARFILZOMIB: A CAUSE OF DRUG ASSOCIATED THROMBOTIC MICROANGIOPATHY. TRANSFUSION AND APHERESIS SCIENCE. 2016;54(3):401-404. | 72.00 | YR | F | Y | 0.00000 | 20160712 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125506431 | 12550643 | 1 | SS | LENALIDOMIDE | LENALIDOMIDE | 1 | Unknown | 0 | |||||||||||
| 125506431 | 12550643 | 2 | PS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | 40069 | |||||||||||
| 125506431 | 12550643 | 3 | C | BORTEZOMIB | BORTEZOMIB | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125506431 | 12550643 | 1 | Plasma cell myeloma |
| 125506431 | 12550643 | 2 | Plasma cell myeloma |
| 125506431 | 12550643 | 3 | Plasma cell myeloma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125506431 | 12550643 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125506431 | 12550643 | Pneumonia | |
| 125506431 | 12550643 | Syncope | |
| 125506431 | 12550643 | Vitreous haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |